4-Hydroxy-2-nonenal (HNE) is a major lipid peroxidation product formed during oxidative stress. Because of its reactivity with nucleophilic compounds, particularly metabolites and proteins containing thiol groups, HNE is cytotoxic. The aim of this study was to assess the extent and time course for the formation of HNE-modified proteins during ischemia and ischemia plus reperfusion in isolated rat hearts. With an antibody to HNE-Cys/His/Lys and densitometry of Western blots, we quantified the amount of HNE-protein adduct in the heart. By taking biopsies from single hearts (n = 5) at various times (0, 5, 10, 15, 20, 35, and 40 min) after onset of zero-flow global ischemia, we showed a progressive, time-dependent increase (which peaked after 30 min) in HNE-mediated modification of a discrete number of proteins. In studies with individual hearts (n = 4/group), control aerobic perfusion (70 min) resulted in a very low level (296 arbitrary units) of HNE-protein adduct formation; by contrast, after 30-min ischemia HNE-adduct content increased by >50-fold (15,356 units, P < 0.05). In other studies (n = 4/group), administration of N-(2-mercaptopropionyl)glycine (MPG, 1 mM) to the heart for 5 min immediately before 30-min ischemia reduced HNE-protein adduct formation during ischemia by ~75%. In studies (n = 4/group) that included reperfusion of hearts after 5, 10, 15, or 30 min of ischemia, there was no further increase in the extent of HNE-protein adduct formation over that seen with ischemia alone. Similarly, in experiments with MPG, reperfusion did not significantly influence the tissue content of HNE-protein adduct. Western immunoblot results were confirmed in studies using in situ immunofluorescent localization of HNE-protein in cryosections. In conclusion, ischemia causes a major increase in HNE-protein adduct that would be expected to reflect a toxic sequence of events that might act to compromise tissue survival during ischemia and recovery on reperfusion.

oxidant stress; free radical; lipid peroxidation; reperfusion

This article has been cited by other articles:

				J. Luo, B. G. Hill, Y. Gu, J. Cai, S. Srivastava, A. Bhatnagar, and S. D. Prabhu Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3673 - H3684. [Abstract] [Full Text] [PDF]

				K. V. Ramana, A. Bhatnagar, S. Srivastava, U. C. Yadav, S. Awasthi, Y. C. Awasthi, and S. K. Srivastava Mitogenic Responses of Vascular Smooth Muscle Cells to Lipid Peroxidation-derived Aldehyde 4-Hydroxy-trans-2-nonenal (HNE): ROLE OF ALDOSE REDUCTASE-CATALYZED REDUCTION OF THE HNE-GLUTATHIONE CONJUGATES IN REGULATING CELL GROWTH J. Biol. Chem., June 30, 2006; 281(26): 17652 - 17660. [Abstract] [Full Text] [PDF]

				K. R. Wildsmith, C. J. Albert, D. S. Anbukumar, and D. A. Ford Metabolism of Myeloperoxidase-derived 2-Chlorohexadecanal J. Biol. Chem., June 23, 2006; 281(25): 16849 - 16860. [Abstract] [Full Text] [PDF]

				A. K. Thukkani, B. D. Martinson, C. J. Albert, G. A. Vogler, and D. A. Ford Neutrophil-mediated accumulation of 2-ClHDA during myocardial infarction: 2-ClHDA-mediated myocardial injury Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2955 - H2964. [Abstract] [Full Text] [PDF]

				M. Benderdour, G. Charron, B. Comte, R. Ayoub, D. Beaudry, S. Foisy, D. deBlois, and C. Des Rosiers Decreased cardiac mitochondrial NADP+-isocitrate dehydrogenase activity and expression: a marker of oxidative stress in hypertrophy development Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2122 - H2131. [Abstract] [Full Text] [PDF]

				G. W. Moe, J. Marin-Garcia, A. Konig, M. Goldenthal, X. Lu, and Q. Feng In vivo TNF-{alpha} inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1813 - H1820. [Abstract] [Full Text] [PDF]

				O. R. Kunduzova, G. Escourrou, F. De La Farge, R. Salvayre, M.-H. Seguelas, N. Leducq, F. Bono, J.-M. Herbert, and A. Parini Involvement of Peripheral Benzodiazepine Receptor in the Oxidative Stress, Death-Signaling Pathways, and Renal Injury Induced by Ischemia-Reperfusion J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2152 - 2160. [Abstract] [Full Text] [PDF]

				M. Canton, I. Neverova, R. Menabo, J. Van Eyk, and F. Di Lisa Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H870 - H877. [Abstract] [Full Text] [PDF]

				I. E. Peterside, M. A. Selak, and R. A. Simmons Impaired oxidative phosphorylation in hepatic mitochondria in growth-retarded rats Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1258 - E1266. [Abstract] [Full Text] [PDF]

				K. Nakamura, K. Kusano, Y. Nakamura, M. Kakishita, K. Ohta, S. Nagase, M. Yamamoto, K. Miyaji, H. Saito, H. Morita, et al. Carvedilol Decreases Elevated Oxidative Stress in Human Failing Myocardium Circulation, June 18, 2002; 105(24): 2867 - 2871. [Abstract] [Full Text] [PDF]

				S. Ivanova, F. Batliwalla, J. Mocco, S. Kiss, J. Huang, W. Mack, A. Coon, J. W. Eaton, Y. Al-Abed, P. K. Gregersen, et al. Neuroprotection in cerebral ischemia by neutralization of 3-aminopropanal PNAS, April 8, 2002; (2002) 82609299. [Abstract] [Full Text] [PDF]

				L. M. Walker, J. L. York, S. Z. Imam, S. F. Ali, K. L. Muldrew, and P. R. Mayeux Oxidative Stress and Reactive Nitrogen Species Generation during Renal Ischemia Toxicol. Sci., September 1, 2001; 63(1): 143 - 148. [Abstract] [Full Text] [PDF]